Statistical considerations for noninferiority/equivalence trials in vaccine development

WWB Wang, DV Mehrotra, ISF Chan… - Journal of …, 2006 - Taylor & Francis
Noninferiority/equivalence designs are often used in vaccine clinical trials. The goal of these
designs is to demonstrate that a new vaccine, or new formulation or regimen of an existing …
被引用次数：44 相关文章
[PDF] researchgate.net

[PDF][PDF] STATISTICAL CONSIDERATIONS FOR NONINFERIORITY/EQUIVALENCE TRIALS IN VACCINE DEVELOPMENT

WWB Wang, DV Mehrotra, ISF Chan… - Journal of …, 2006 - researchgate.net
Noninferiority/equivalence designs are often used in vaccine clinical trials. The goal of these
designs is to demonstrate that a new vaccine, or new formulation or regimen of an existing …

Statistical considerations for noninferiority/equivalence trials in vaccine development

WWB Wang, DV Mehrotra… - Journal of …, 2006 - pubmed.ncbi.nlm.nih.gov
Noninferioritylequivalence designs are often used in vaccine clinical trials. The goal of these
designs is to demonstrate that a new vaccine, or new formulation or regimen of an existing …

Statistical Considerations for NonInferiority/Equivalence Trials in Vaccine Development

WWB Wang, DV Mehrotra, ISF Chan… - Journal of …, 2006 - ingentaconnect.com
Noninferiority/equivalence designs are often used in vaccine clinical trials. The goal of these
designs is to demonstrate that a new vaccine, or new formulation or regimen of an existing …

Statistical considerations for noninferiority/equivalence trials in vaccine development.

WW Wang, DV Mehrotra, IS Chan… - Journal of …, 2006 - europepmc.org
Noninferioritylequivalence designs are often used in vaccine clinical trials. The goal of these
designs is to demonstrate that a new vaccine, or new formulation or regimen of an existing …